All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis

News
1

Patients with schizophrenia receiving antipsychotic treatment present lower mortality rates than those who do not. However, the non-adherence rate is high, which can be partially addressed using long-acting injectable (LAI) antipsychotics

https://www.nature.com/articles/s41380-024-02694-3

2 Likes
2

@everhopeful ,seems that LAI wins?

2 Likes